NCIMB Secures £1.7m Investment for Growth and Expansion

NCIMB, a leading microbiology services provider in the UK, has received a significant investment of £1.7 million from Maven Capital Partners through the Investment Fund for Scotland (IFS) and the Scottish National Investment Bank. This funding aims to bolster NCIMB's business development and marketing efforts, thereby accelerating its growth in the microbiology and strain licensing sectors. Already renowned for its extensive bacterial culture collection that serves various industries including pharmaceuticals and biotechnology, NCIMB plans to expand its services to include developing bacterial strains for specific applications. The firm intends to address significant challenges such as climate change and food security by deploying its microbiology expertise. This investment also marks Maven's continued commitment to nurturing high-potential businesses in Scotland across different sectors. Key stakeholders from Maven and the Scottish National Investment Bank emphasize the transformative potential of this investment in aligning NCIMB with global sustainability and efficiency goals.